Experimental study of combined portal vein embolization with hepatocyte growth factor injection in liver regeneration in hepatic cirrhosis

YU Hong-jian,LIU Peng-cheng,CHEN Zai-zhong,QIN Wen,DAI Lu-ping,WANG Zi-hui
DOI: https://doi.org/10.3969/j.issn.1006-9011.2007.04.022
2007-01-01
Journal of Medical Imaging
Abstract:Objective:To evaluate the usefulness of combination PVE with HGF injection in liver regeneration after PVE in fibrotic rabbit model.Methods:Twenty hepatic fibrotic rabbit models were randomly divided into the HGF group(n=10) and control group(n=10).PVE was peformed by using a combination of a mixture of absolute ethanol-lipodol in both group.For the HGF group,a bolus infusion of HGF was administered four times,at 0.5 h following PVE through the intraportal catheter,at 24,48 and 72h following PVE by intra-peritoneal injection.Normal saline was injected using the same time schedule into the control rabbits.Regular examination of computed tomography and portal angiography were made.The degree of hypertrophy of non-embolized liver segment were compared.After the rabbits were sacrificed,the specimens were pathologically examined.All the data were statistically analyzed.Results:The PVE process was success in both group.In both groups,recanalization of some of the embolized portal branches could be seen.A 15.97%±2.54 hypertrophy of non-embolized liver was achieved in HGF group.The hypertrophy percentage of non-embolized liver was 7.65%±2.48 in the control group.Significant difference in hypertrophy percentage of non-embolized liver existed between two groups(P<0.05).Conclusion:A more great degree of hypertrophy on non-embolized liver segment can be achieved by using HGF after portal vein embolization.
What problem does this paper attempt to address?